N/A (healthy adults)
Conditions
Interventions
Subjects will consume the test food for 12 weeks.
Subjects will consume placebo food for 12 weeks
Sponsors
Ajinomoto Co.,Inc.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: [1]Female aged between 40 and 60 at the time of informed consent [2]Individuals who are healthy and have no chronic physical disease including skin disease. [3]Individuals who are aware of skin deterioration such as elasticity and sagging [4]Individuals whose written informed consent has been obtained. [5]Individuals who can come to the designated venue for this study and be inspected. [6]Individuals judged appropriate for this study by a responsible doctor.
Exclusion criteria
Exclusion criteria: [1]contract disease and are under treatment. [2]undergoing hormone replacement procedures. [3]with skin disease,such as atopic dermatitis. [4]with strange skin conditions at measurement points. [5]used a drug to treat a disease in the past 1 month. [6]have a history of and/or contract serious diseases (eg,liver disease,kidney disease, heart disease,lung disease,blood disease). [7]have a history and/or contract digestive disease. [8]with psychiatric disease. [9]with serious anemia. [10]whose BMI are 30 or more. [11]have allergic reaction to ingredients of test foods and other foods or drugs. [12]have a habit to use functional foods and/or supplements containing collagen, specified amino acids in the past 3 months and/or are planning to use those foods during study periods. [13]have a habit to use Foods with Function Claims, functional foods and/or supplements claiming to improve skin function and/or Anti-glycation in the past 3 months and/or are planning to use those foods during study periods. [14]have a habit to use drugs claiming to improve skin function in the past 3 months. [15]are or are possibly pregnant, or are breastfeeding. [16]are smokers. [17]drink more than 60g/day on average in terms of pure alcohol. [18]with possible changes of life style during study periods. [19]will develop seasonal allergy symptoms, such as pollinosis, use an anti-allergic drug. [20]neglect skin care. [21]have undergone or will undergo facial cosmetic procedures such as facial peels, laser or other facial cosmetic treatments, beauty treatments at esthetic clinics, spas, etc., or facial art makeup in the past 4 weeks or during study period. [22]can't avoid direct sunlight exposure, such as sunburn, during study periods. [23]are participating and/or had participated in other clinical studies within the last 3 months. [24]are judged as not appropriate to this study by a responsible doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin viscoelasticity R2 and R7 at week 12 of intake | — |
Secondary
| Measure | Time frame |
|---|---|
| Fluorescent AGEs (AF),Skin viscoelasticity(R0,R5,R6),Transepidermal water loss,Moisture of the skin surface,VISIA score,Skin color quantification,Observation for skin condition by dermatologists,Skin Awareness Questionnaire | — |
Countries
Japan
Contacts
Public ContactSeigo Isozaki
Anti-Aging Bank Co.,Ltd. Clinical trial support team
Outcome results
None listed